Literature DB >> 15217658

Oxidative stress and mitochondrial glutathione in human lymphocytes exposed to clinically relevant anesthetic drug concentrations.

Giovanna Delogu1, Adriana Antonucci, Sonia Moretti, Maurizio Marandola, Guglielmo Tellan, Michele Signore, Giuseppe Famularo.   

Abstract

STUDY
OBJECTIVE: To evaluate the potential of compounds commonly used in anesthesia practice to affect the intracellular oxidant-antioxidant homeostasis of peripheral blood lymphocytes at clinically relevant concentrations; and to study the changes in reactive oxygen species production and measure the mitochondrial glutathione content.
DESIGN: Prospective, in vitro study.
SETTING: Experimental medical research laboratory at a University Hospital. MEASUREMENTS: Lymphocytes were isolated from the peripheral blood of 15 healthy donors and incubated for 12 hours at 37 degrees C with the following drug concentrations: thiopental sodium 20 mmoL/mL, droperidol 130 micromol/mL, propofol 60 mmoL/mL, and succinylcholine 17 mmoL/mL. Reactive oxygen species (ROS) generation was determined by hydroethidine and 2',7'-dichlorofluorescein diacetate methods. Mitochondrial glutathione level was assessed using monobromobimane staining.
MEASUREMENTS AND MAIN RESULTS: Thiopental-treated lymphocytes exhibited an overgeneration of ROS, but no change was detected in mitochondrial glutathione quantity. Propofol and droperidol could not induce any perturbative effect on the oxidative state of T cells, whereas succinylcholine was found to markedly affect lymphocyte oxidative state both by impairing glutathione content and promoting exaggerated production of ROS.
CONCLUSION: Drugs commonly used in anesthesia practice may significantly alter the oxidative state of peripheral T cells. This mechanism could contribute to the immune suppression that occurs transiently in the early postoperative period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217658     DOI: 10.1016/j.jclinane.2003.07.007

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  7 in total

Review 1.  Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Authors:  Namrita Halder; Girdhari Lal
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

2.  Propofol inhibits pressure-stimulated macrophage phagocytosis via the GABAA receptor and dysregulation of p130cas phosphorylation.

Authors:  Hiroe Shiratsuchi; Yasser Kouatli; Guang Xiang Yu; Harold M Marsh; Marc D Basson
Journal:  Am J Physiol Cell Physiol       Date:  2009-04-08       Impact factor: 4.249

Review 3.  Anesthesia for children with mitochondrial disorders: a national survey and review.

Authors:  Muhammad B Rafique; Staci D Cameron; Qaiser Khan; Suur Biliciler; Salman Zubair
Journal:  J Anesth       Date:  2012-09-25       Impact factor: 2.078

4.  Propofol protects against hydrogen peroxide-induced oxidative stress and cell dysfunction in human umbilical vein endothelial cells.

Authors:  Jiawei Chen; Yuechao Gu; Zhiming Shao; Jianmin Luo; Zhiming Tan
Journal:  Mol Cell Biochem       Date:  2009-12-29       Impact factor: 3.396

5.  Increased HMGB1 expression and release by mononuclear cells following surgical/anesthesia trauma.

Authors:  Valeria Manganelli; Michele Signore; Ilaria Pacini; Roberta Misasi; Guglielmo Tellan; Tina Garofalo; Emanuela Lococo; Piero Chirletti; Maurizio Sorice; Giovanna Delogu
Journal:  Crit Care       Date:  2010-11-02       Impact factor: 9.097

6.  Treating critical illness: the importance of first doing no harm.

Authors:  Mervyn Singer; Paul Glynne
Journal:  PLoS Med       Date:  2005-06-28       Impact factor: 11.069

7.  Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer.

Authors:  Songtao Liu; Xinyu Gu; Lijiao Zhu; Guannan Wu; Hai Zhou; Yan Song; Congyou Wu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.